Adaptive Biotechnologies Corporation Common Stock (ADPT) is a publicly traded Healthcare sector company. As of September 1, 2026, ADPT trades at $23.90 with a market cap of $3.98B and a P/E ratio of -59.63. ADPT moved -2.41% today. Year to date, ADPT is +52.99%; over the trailing twelve months it is +89.56%. Its 52-week range spans $5.98 to $26.87. Analyst consensus is strong buy with an average price target of $25.07. Rallies surfaces ADPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover ADPT: 0 strong buy, 7 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $25.07.
| Metric | Value |
|---|---|
| Price | $23.90 |
| Market Cap | $3.98B |
| P/E Ratio | -59.63 |
| EPS | $-0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.87 |
| 52-Week Low | $5.98 |
| Volume | 1.42M |
| Avg Volume | 0 |
| Revenue (TTM) | $308.08M |
| Net Income | $-63.99M |
| Gross Margin | 75.57% |
8 analysts cover ADPT: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.07.